15-Ketolatanoprost acid is a potential metabolite of latanoprost in animals and a common minor impurity in commercial drug formulations. Although its potency is significantly lower than that of the parent compound latanoprost, it can still produce a slight but measurable reduction in intraocular pressure (by 1 mmHg) in normal cynomolgus monkeys at a dose of 1 μg/eye. It also acts as a miotic agent in normal feline eyes, reducing pupil diameter by 8 mm at a dose of 5 μg/eye, though it is less effective than many other prostaglandin F-type compounds (e.g., prostaglandin F2α achieves similar miosis at doses below 1 μg/eye).